Some groups of patients with clinically localized kidney tumors and severe chronic kidney disease (CKD) are at high risk of adverse outcomes after partial nephrectomy (PN), according to a study in The Journal of Urology.
The retrospective study included 62 patients with clinically localized kidney tumors (T1-T2/N0M0) and stage 4 CKD who underwent PN at the Cleveland Clinic between 1999 and 2015. The patients were 44 men and 18 women, median age 67 years. Comorbid diseases were common, including hypertension in 94% of patients, cardiovascular disease in 53%, and diabetes in 32%. Median estimated glomerular filtration rate (eGFR)